Skip to content
Abierto

Award notice

Serological Assays for the Detection and Characterization of Influenza Viruses

0001

Centers for Disease Control and Prevention, CDC Office of Acquisition Services. In-Vitro Diagnostic Substance Manufacturing.

Awarded

American Type Culture Collection

$7,335,701.00 on the award notice, May 18, 2026, contract 75D30126C21030

Description

As published on SAM.gov.

The objective of this contract is to support the Influenza Division through the testing of human sera via hemagglutination inhibition assay as well as develop a new serology platform that is comparable to hemagglutination inhibition assay.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
KT4MLLHK99V6
CAGE
31101
Vendor location
Manassas, VA
Contract
75D30126C21030, definitive contract
Obligated
$497,780.00, potential $7,335,701
Actions
2 between May 18, 2026 and June 9, 2026
Competition
Full and Open Competition, 5 offers received
Set-aside reported
No Set Aside Used.
Described as
Eo 14398 Perform Influenza Serology Testing.
Match
award number 75D30126C21030 equals the contract number; same awarding office 75D301 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 18, 2026

    Award notice, originally solicitation

    Awarded to AMERICAN TYPE CULTURE COLLECTION Manassas for $7,335,701. SAM.gov, notice 9d0442265d384ee69781b81886573570

Points of contact